Lawrence Kushi to Antineoplastic Agents
This is a "connection" page, showing publications Lawrence Kushi has written about Antineoplastic Agents.
Connection Strength
1.121
-
BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. J Natl Cancer Inst. 2017 02; 109(2).
Score: 0.481
-
Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings. Int J Cancer. 2026 Mar 15; 158(6):1481-1488.
Score: 0.226
-
Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. JAMA Oncol. 2016 Sep 01; 2(9):1170-6.
Score: 0.119
-
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival. Clin Cancer Res. 2016 Dec 01; 22(23):5909-5914.
Score: 0.119
-
Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
Score: 0.105
-
Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer. Breast Cancer. 2014 Nov; 21(6):780-5.
Score: 0.025
-
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101.
Score: 0.023
-
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60.
Score: 0.023